Werdegang mit den wichtigsten Stationen
2018 - 2021 Bereichsleiter für PharmaBiotech am Naturwissenschaftlichen und Medizinischen Institut (NMI), Reutlingen
2011 - heute Professor der pharmazeutischen Biotechnologie an der Universität Tübingen (Brückenprofessur Universität Tübingen und dem Naturwissenschaftlichen und Medizinischen Institut (NMI) in Reutlingen
2008 – 2011 Geschäftsführer der ChromoTek GmbH (Martinsried, Deutschland)
2008 – 2010 GO-Bio Nachwuchsgruppenleiter, Biozentrum, LMU München
2006 – 2007 Exist-Seed Projektleiter, Biozentrum, LMU München
2004 – 2005 Post-Doc bei Prof. Dr. Heinrich Leonhardt, Biozentrum, LMU München
2003 – 2004 Post-Doc bei PD Dr. Mathias Bauer, Institut für Diabetes Forschung, München Klinik Schwabing
1999 – 2003 Dissertation (Dr. rer. nat.; PhD) bei Prof. Dr. Dr. Walter Neupert am Adolf-Butenandt-Institut, LMU, München zum Thema "Functional characterization of a mitochondrial mediate disease: The role of DDP1 and Tim13 for mitochondrial biogenesis".
1998 Diplomarbeit bei Prof. Dr. Svante Pääbo am zoologischen Institut der LMU München zum Thema „In vitro processing of overlapping tRNA transcripts in human mitochondria“
1992 – 1998 Studium der Biologie an der Ludwig-Maximilians Universität (LMU) München
Prof. Dr. Ulrich Rothbauer
Diplom-Biologe
Publikationen
-
The interaction between anti-PF4 antibodies and anticoagulants in vaccine-induced thrombotic thrombocytopeniaSingh, A., Toma, F., Uzun, G., Wagner, T., Pelzl, L., Zlamal, J., Freytag, V., Weich, K., Nowak-Hamau, S., Rothbauer, U., Althaus, K., Bakchoul, T.https://doi.org/10.1182/blood.2021013839
-
A Nanobody-Based Toolset to Monitor and Modify the Mitochondrial GTPase Miro1Fagbadebo, F., Kaiser, P., Zittlau, K., Bartlick, N., Wagner, T., Fröhlich, T., Jarjour, G., Nueske, S., Scholz, A., Tränkle, B., Macek, B., Rothbauer, U.https://doi.org/10.3389/fmolb.2022.835302
-
Four-color single-molecule imaging with engineered tags resolves the molecular architecture of signaling complexes in the plasma membraneBellon J, Birkholz O, Richter C, Walter M, Kurre R, Piehler J, Eull F, Kenneweg H, Wilmes S, Rothbauer U, You C,Sotolongo Bello´ n et al., 2022, Cell Reports Methods 2, 100165 February 28, 2022 ª 2022 The Authors. https://doi.org/10.1016/j.crmeth.2022.100165
-
Decisive role of water and protein dynamics in residence time of p38α MAP kinase inhibitorsPantsar T, Kaiser P, Kudolo M, Forster M, Rothbauer U, Laufer SNature Communications volume 13, Article number: 569 (2022)
-
Robust and durable serological response following pediatric SARS-CoV-2 infectionRenk H, Dulovic A, Seidel A, Becker M, Fabricius D, Zernickel M, Junker D, Groß R, Müller J, Hilger A, Bode S, Fritsch L, Frieh P, Haddad A, Görne T, Remppis J, Ganzemueller T, Dietz A, Huzly D, Hengel H, Kaier K, Weber S, Jacobsen E, Kaiser P, Tränkle B, Rothbauer U, Stich M, Tönshoff B, Hoffmann G, Müller B, Ludwig C, Jahrsdörfer B, Schrezenmeier H, Peter A, Hörber S, Iftner T, Münch J, Stamminger T, Groß H, Wolkewitz M, Engel C, Liu W, Rizzi M, Hahn B, Henneke P, Franz A, Debatin K, Schneiderhan-Marra N, Janda A, Elling RNature Communications volume 13, Article number: 128 (2022); https://doi.org/10.1038/s41467-021-27595-9
-
Single-Domain Antibodies for Targeting, Detection, and In Vivo Imaging of Human CD4+ CellsTraenkle B, Kaiser PD, Pezzana S, Richardson J, Gramlich M, Wagner TR, Seyfried D, Weldle M, Holz S, Parfyonova Y, Nueske S, Scholz AM, Zeck A, Jakobi M, Schneiderhan-Marra N, Schaller M, Maurer A, Gouttefangeas C, Kneilling M, Pichler BJ, Sonanini D, Rothbauer UFront Immunol. 2021 Dec 9;12:799910. doi: 10.3389/fimmu.2021.799910. PMID: 34956237; PMCID: PMC8696186.
-
Nanobodies - Little helpers unravelling intracellular signalingWagner TR, Rothbauer UFree Radic Biol Med. 2021 Nov 20;176:46-61. doi: 10.1016/j.freeradbiomed.2021.09.005. Epub 2021 Sep 15. PMID: 34536541.
-
Reduced serum neutralization capacity against SARS-CoV-2 variants in a multiplex ACE2 RBD competition assayJunker D, Dulovic A, Becker M, Wagner T R, Kaiser P D, Traenkle B, Rothbauer U, Kienzle K, Bunk S, Strümper C, Häberle H, Schmauder K, Malek N, Althaus K, Koeppen M, Bitzer M, Göpel S, Schneiderhan-Marra NmedRxiv, https://doi.org/10.1101/2021.08.20.21262328
-
Diminishing immune responses against variants of concern in dialysis patients four months after SARS-CoV-2 mRNA vaccinationDulovic A, Strengert M, Morillas Ramos G, Becker M, Griesbaum J, Junker D, Lürken K, Beigel A, Wrenger E, Lonnemann G, Cossmann A, Stankov M, Dopfer-Jablonka A, Kaiser P, Traenkle B, Rothbauer U, Krause G, Schneiderhan-Marra N, Behrens G M.N.medRxiv, https://doi.org/10.1101/2021.08.16.21262115
-
Tris(hydroxymethyl)aminomethane Compatibility with N-Hydroxysuccinimide Ester Chemistry: Biotinylation of Peptides and Proteins in TRIS BufferKratzer U, Sommersdorf C, Maier S, Wagner TR, Templin M, Joos TO, Rothbauer U, Zeck A, Poetz OBioconjug Chem. 2021 Sep 15;32(9):1960-1965. doi: https://doi.org/10.1021/acs.bioconjchem.1c00283. Epub 2021 Aug 18. PMID: 34406760.
-
A broadly neutralizing biparatopic Nanobody protects mice from lethal challenge with SARS-CoV-2 variants of concernWagner T, Schnepf D, Beer J, Klingel K, Ruetalo N, Kaiser P, Junker D, Sauter M, raenkle B, Frecot D, Becker M, Schneiderhan-Marra N, Ohnemus A, Schwemmle M, Schindler M, Rothbauer UbioRxiv, doi: https://doi.org/10.1101/2021.08.08.455562
-
Parallelizable Microfluidic Platform to Model and Assess In Vitro Cellular Barriers: Technology and Application to Study the Interaction of 3D Tumor Spheroids with Cellular BarriersNair A L , Mesch L, Schulz I, Becker H , Raible J, Kiessling H, Werner S, Rothbauer U , Schmees C, Busche M, Trennheuser S, Fricker G and Stelzle MBiosensors 2021, 11, 314. https://doi.org/10.3390/bios11090314
-
Typically asymptomatic but with robust antibody formation: Children’s unique humoral immune response to SARS-CoV-2.Renk H, Dulovic A, Becker M, Fabricius D, Zernickel M, Junker D, Seidel A, Groß R, Hilger A, Bode S, Fritsch L, Frieh P, Haddad A, Görne T, Remppis J, Ganzemueller T, Dietz A, Huzly D, Hengel H, Kaier K, Weber S, Jacobsen EM, Kaise P, Traenkle B, Rothbauer U, Stich M, Tönshoff B, Hoffmann H, Müller B, Ludwig C, Jahrsdörfer B, Schrezenmeier H, Peter A, Hörber S, Iftner T, Münch J, Stamminger T, Groß HJ, Wolkewitz M, Engel C, Rizzi M, Henneke P, Franz AR, Debatin KM, Schneiderhan-Marra N, Janda A, Elling RmedRxiv, doi: https://doi.org/10.1101/2021.07.20.21260863
-
Generation and characterization of the human induced pluripotent stem cell line NMIi010-A from peripheral blood mononuclear cells of a healthy 49–year old male individualKeller AK, Binner A, Breitmeyer R, Vogel S, Anderle N, Rothbauer U, Schenke-Layland K, Schmees CStem Cell Research Volume 54, July 2021, 102427, https://doi.org/10.1016/j.scr.2021.102427
-
A purification platform for antibodies and derived fragments using a de novo designed affinity adsorbentM.J.B. Matos, F. Trovão, J. Gonçalves, U. Rothbauer, M.G. Freire, A.M.J.B. Barbosa, A.S. Pina, A.C.A. Roquehttps://doi.org/10.1016/j.seppur.2021.118476
-
Generation and characterization of the human induced pluripotent stem cell line NMIi010-A from peripheral blood mononuclear cells of a healthy 49–year old male individualKeller AL, Binner A, Breitmeyer R, Vogel S, Anderle N, Rothbauer U, Schenke-Layland K, Schmees Ctem Cell Res. 2021 Jul;54:102427. doi: 10.1016/j.scr.2021.102427. Epub 2021 Jun 11. PMID: 34139596.
-
Immune response to SARS-CoV-2 variants of concern in vaccinated individualsBecker M, Dulovic A, Junker D, Ruetalo N, PKaiser PD, Pinilla YT, Heinzel C, Haering J, Traenkle B, Wagner TR, Layer M, Mehrlaender M, Mirakaj V, Held J, Planatscher H, Schenke-Layland K, Krause G, Strengert M, Bakchoul T, Althaus K, Fendel R, Kreidenweiss A, Koeppen M, Rothbauer U, Schindler M & Schneiderhan-Marra NNATURE COMMUNICATIONS| (2021) 12:3109 | https://doi.org/10.1038/s41467-021-23473-6 | www.nature.com/naturecommunications11234567890():,;
-
NeutrobodyPlex - monitoring SARS-CoV-2 neutralizing immune responses using nanobodiesWagner TR, Ostertag E, Kaiser PD, Gramlich M, Ruetalo N, Junker D, Haering J, Traenkle B, Becker M, Dulovic A, Schweizer H, Nueske S, Scholz A, Zeck A, Schenke-Layland K, Nelde A, Strengert M, Walz JS, Zocher G, Stehle T, Schindler M, Schneiderhan-Marra N, Rothbauer UEMBO Rep. 2021 May 5;22(5):e52325. doi: 10.15252/embr.202052325. Epub 2021 Apr 27. PMID: 33904225; PMCID: PMC8097376.
-
HDX-MS for Epitope Characterization of a Therapeutic ANTIBODY Candidate on the Calcium-Binding Protein Annexin-A1Gramlich M, Hays HCW, Crichton S, Kaiser PD, Heine A, Schneiderhan-Marra N, Rothbauer U, Stoll D, Maier S, Zeck AAntibodies (Basel). 2021 Mar 19;10(1):11. doi: 10.3390/antib10010011. PMID: 33808657; PMCID: PMC8006148. Copy Downloa
-
Multiplexed Serum Antibody Screening Platform Using Virus Extracts from Endemic Coronaviridae and SARS-CoV-2Fink S., Ruoff F., Stahl A., Becker M., Kaiser P., Traenkle B., Junker D., Weise F., Ruetalo N., Hörber S., Peter A., Nelde A., Walz j., Krause G., Baillot A., Schenke-Layland K., Joos TO., Rothbauer U., Schneiderhan-Marra N., Schindler M., Templin MFACS Infectious Diseases 2021; https://doi.org/10.1021/acsinfecdis.0c00725.
-
Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivityBecker M, Strengert M, Junker D, Kaiser P, Kerrinnes T, Traenkle B, Dinter H, Häring J, Ghozzi S, Zeck A, Weise F, Peter A, Hörber S, Fink S, Ruoff F, Dulovic A, Bakchoul T, Baillot A, Lohse S, Cornberg M, Illig T, Gottlieb J, Smola S, Karch A, Berger K, Rammensee HG, Schenke-Layland K, Nelde A, Märklin M, Heitmann JS, Walz JS, Templin M, Joos TO, Rothbauer U, Krause K & Schneiderhan-Marra NNATURE COMMUNICATIONS | (2021) 12:1152 | https://doi.org/10.1038/s41467-021-20973-3 | www.nature.com/naturecommunications
-
Magnetic Bead-Based Immunoassay Allows Rapid, Inexpensive, and Quantitative Detection of Human SARS-CoV-2 AntibodiesHuergo LF, Selim KA, Conzentino MS, Gerhardt ECM, Santos ARS, Wagner B, Alford JT, Deobald N, Pedrosa FO, de Souza EM, Nogueira MB, Raboni SM, Souto D, Rego FGM, Zanette DL, Aoki MN, Nardin JM, Fornazari B, Morales HMP, Borges VA, Nelde A, Walz JS, Becker M, Schneiderhan-Marra N, Rothbauer U, Reis RA, Forchhammer KACS Sensors 2021, 6(3):703-708, https://doi.org/10.1021/acssensors.0c02544
-
NeutrobodyPlex - Nanobodies to monitor a SARS-CoV-2 neutralizing immune responseWagner T., Ostertag E., Kaiser P., Gramlich M., Ruetalo N., Junker D., Haering J., Traenkle B., Becker M., Dulovic A., Schweizer H., Nueske S., Scholz A., Zeck A., Schenke-Layland K., Nelde A., Strengert M., Walz J., Zocher G., Stehle T., Schindler M., Schneiderhan-Marra N., Rothbauer UIn EMBO Reports 2021; 22(5):e52325. https://doi.org/10.15252/embr.202052325
-
SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognitionNelde A., Bilich T., Heitmann JS., Maringer Y., Salih HR., Roerden R., Luebke M., Bauer J., Rieth J., Wacker M., Peter A., Hörber S., Traenkle B., Kaiser PD., Rothbauer U., Becker M., Junker D., Krause G., Strengert M., Schneiderhan-Marra N., Joos TO., Kowalewski D.J., Stos-Zweifel V., Fehr M., Graf M., Gruber L., Rachfalski D., Preuß B., Hagelstein I., Märklin M., Bakchoul T., Gouttefangeas C., Kohlbacher O., Klein R., Stevanović S., Rammensee H.-G., Walz J.S.Nature Immunology 2021; 22:74–85, DOI: https://doi.org/10.1038/s41590-020-00808-x
-
A novel epitope tagging system to visualize and monitor antigens in live cells with chromobodiesTraenkle B, Segan S, Funmilayo F , Kaiser P, Rothbauer UScientific Reports, 10, (2020) 10:14267, https://doi.org/10.1038/s41598-020-71091-x
-
Systematic Investigation of Polyurethane Biomaterial Surface Roughness on Human Immune Responses in vitroSegan S, Jakobi M, Khokhani P, Klimosch S, Billing F, Schneider M, Martin D, Metzger U, Biesemeier A, Xiong X, Mukherjee A, Steuer H, Keller B-M, Joos T, Schmolz M, Rothbauer U, Hartmann H, Burkhardt C, Lorenz G ,Schneiderhan-Marra N, and Shipp CBioMed Research International, 2020, https://doi.org/10.1155/2020/3481549
-
A Strategy to Optimize the Generation of Stable Chromobody Cell Lines for Visualization and Quantification of Endogenous Proteins in Living CellsKeller B, Maier J, Weldle M, Segan S, Traenkle B, Rothbauer UAntibodies 2019, 8, 10; doi:10.3390/antib8010010
-
Chromobodies to quantify changes of endogenous protein concentration in living cellsKeller BM, Maier J, Secker KA, Egetemaier SM, Parfyonova Y, Rothbauer U, Traenkle BMol Cell Proteomics. 2018 Dec;17(12):2517-2533. doi: 10.1074/mcp.TIR118.000914. Epub 2018 Sep 18.
-
Speed up to find the right ones: rapid discovery of functional nanobodiesRothbauer UNat Struct Mol Biol. 2018 Mar;25(3):199-201.
-
A peptide tag-specific nanobody enables high-quality labeling for dSTORM imagingVirant D, Traenkle B, Maier J, Kaiser PD, Bodenhöfer M, Schmees C, Vojnovic I, Pisak-Lukáts B, Endesfelder U, Rothbauer UNature Communications. 2018 Mar;9:930. DOI:10.1038/s41467-018-03191-2
-
Akt1 and Akt3 but not Akt2 through interaction with DNA-PKcs stimulate proliferation and post-irradiation cell survival of K-RAS-mutated cancer cellsToulany M, Maier J, Iida M, Rebholz S, Holler M, Grottke A, Jüker M, Wheeler DL, Rothbauer U, Rodemann HPCell Death Discovery. 2017; 3:17072
-
Under the Microscope: Single-Domain Antibodies for Live-Cell Imaging and Super-Resolution MicroscopyTraenkle B, Rothbauer UFront Immunol. 2017 Aug 24;8:1030. doi: 10.3389/fimmu.2017.01030. eCollection 2017.
-
A Nexus Consisting of Beta-Catenin and Stat3 Attenuates BRAF Inhibitor Efficacy and Mediates Acquired Resistance to VemurafenibSinnberg T, Makino E, Krueger MA, Velic A, Macek B, Rothbauer U, Groll N, Potz O, Czemmel S, Niessner H, Meier F, Ikenberg K, Garbe C, Schittek BEBioMedicine. 2016 Jun;8:132-49. doi: 10.1016/j.ebiom.2016.04.037. Epub 2016 May 1.
-
Role of BCL9L in transforming growth factor-beta (TGF-beta)-induced epithelial-to-mesenchymal-transition (EMT) and metastasis of pancreatic cancerSannino G, Armbruster N, Bodenhofer M, Haerle U, Behrens D, Buchholz M, Rothbauer U, Sipos B, Schmees COncotarget. 2016 Oct 4; 7:73725-73738. doi: 10.18632/oncotarget.12455.
-
Nanobody Platform for Determination of Protein Structure, Application of Peptides and ProteinsTraenkle B, Kaiser PD, Rothbauer U2016. in: Encyclopedia of Analytical Chemistry, John Wiley & Sons, Ltd, 2006.
-
From Enzyme to Whole Blood: Sequential Screening Procedure for Identification and Evaluation of p38 MAPK InhibitorsBauer SM, Kubiak JM, Rothbauer U, Laufer SMethods Mol Biol. 2016;1360:123-48. doi: 10.1007/978-1-4939-3073-9_10.
-
A Multiplexed High-Content Screening Approach Using the Chromobody Technology to Identify Cell Cycle Modulators in Living CellsSchorpp K, Rothenaigner I, Maier J, Traenkle B, Rothbauer U, Hadian KJ Biomol Screen. 2016 Oct;21(9):965-77. doi: 10.1177/1087057116641935. Epub 2016 Apr 4.
-
A New Nanobody-Based Biosensor to Study Endogenous PARP1 In Vitro and in Live Human CellsBuchfellner A, Yurlova L, Nuske S, Scholz AM, Bogner J, Ruf B, Zolghadr K, Drexler SE, Drexler GA., Girst S, Greubel C, Reindl J, Siebenwirth C, Romer T, Friedl AA, Rothbauer UPLoS One. 2016 Mar 7;11(3):e0151041. doi: 10.1371/journal.pone.0151041. eCollection 2016.
-
Peptides in headlock - a novel high-affinity and versatile peptide-binding nanobody for proteomics and microscopyBraun MB, Traenkle B, Koch PA, Emele F, Weiss F, Poetz O, Stehle T, Rothbauer USci Rep. 2016 Jan 21;6:19211. doi: 10.1038/srep19211.
-
Real-time analysis of epithelial-mesenchymal transition using fluorescent single-domain antibodiesMaier J, Traenkle B, Rothbauer USci Rep. 2015 Aug 21;5:13402. doi: 10.1038/srep13402.
-
Live imaging of endogenous protein dynamics in zebrafish using chromobodies.Panza P, Maier J, Schmees C, Rothbauer U, Söllner C.Development. 2015 May 15;142(10):1879-84. doi: 10.1242/dev.118943.
-
Monitoring interactions and dynamics of endogenous beta-catenin with intracellular nanobodies in living cellsTraenkle B, Emele F, Anton R, Poetz O, Haeussler RS, Maier J, Kaiser PD, Scholz AM, Nueske S, Buchfellner A, Romer T, Rothbauer UMol Cell Proteomics. 2015 Mar;14(3):707-23. doi: 10.1074/mcp.M114.044016. Epub 2015 Jan 16.
-
Generation of an alpaca-derived nanobody recognizing gamma-H2AXRajan M, Mortusewicz O, Rothbauer U, Hastert FD, Schmidthals K, Rapp A, Leonhardt H, Cardoso MCFEBS Open Bio. 2015 Sep 21;5:779-88. doi: 10.1016/j.fob.2015.09.005. eCollection 2015.
-
Towards multiplexed protein-protein interaction analysis using protein tag-specific nanobodiesGroll N, Emele F, Poetz O, Rothbauer UJ Proteomics. 2015 Sep 8;127(Pt B):289-99. doi: 10.1016/j.jprot.2015.04.017. Epub 2015 May 1.
-
A p38 substrate-specific MK2-EGFP translocation assay for identification and validation of new p38 inhibitors in living cells: a comprising alternative for acquisition of cellular p38 inhibition dataAnton R, Bauer SM, Keck PR, Laufer S, Rothbauer UPLoS One. 2014 Apr 17;9(4):e95641. doi: 10.1371/journal.pone.0095641. eCollection 2014.
-
Recent progress in generating intracellular functional antibody fragments to target and trace cellular components in living cellsKaiser PD, Maier J, Traenkle B, Emele F, Rothbauer UBiochim Biophys Acta. 2014 Nov;1844(11):1933-1942. doi: 10.1016/j.bbapap.2014.04.019. Epub 2014 May 2.
-
c-Jun/c-Fos heterodimers regulate cellular genes via a newly identified class of methylated DNA sequence motifsGustems M, Woellmer A, Rothbauer U, Eck SH, Wieland T, Lutter D, Hammerschmidt WNucleic Acids Res. 2014 Mar;42(5):3059-72. doi: 10.1093/nar/gkt1323. Epub 2013 Dec 25.
-
The Fluorescent Two-Hybrid Assay to Screen for Protein-Protein Interaction Inhibitors in Live Cells: Targeting the Interaction of p53 with Mdm2 and Mdm4Yurlova L, Derks M, Buchfellner A, Hickson I, Janssen M, Morrison D, Stansfield I, Brown CJ, Ghadessy FJ, Lane DP, Rothbauer U, Zolghadr K, Krausz EJ Biomol Screen. 2014 Apr;19(4):516-25. doi: 10.1177/1087057113518067. Epub 2014 Jan 29.
-
A versatile assay for RNA-binding proteins in living cellsStrein C, Alleaume AM, Rothbauer U, Hentze MW, Castello ARNA. 2014 May;20(5):721-31. doi: 10.1261/rna.043562.113. Epub 2014 Mar 24.